Cytokines as biomarkers of nanoparticle immunotoxicity
Top Cited Papers
Open Access
- 3 April 2013
- journal article
- review article
- Published by Royal Society of Chemistry (RSC) in Chemical Society Reviews
- Vol. 42 (12), 5552-5576
- https://doi.org/10.1039/c3cs60064e
Abstract
Nanoscale objects, whether of biologic origin or synthetically created, are being developed into devices for a variety of bionanotechnology diagnostic and pharmaceutical applications. However, the potential immunotoxicity of these nanomaterials and mechanisms by which they may induce adverse reactions have not received sufficient attention. Nanomaterials, depending on their characteristics and compositions, can interact with the immune system in several ways and either enhance or suppress immune system function. Cytokines perform pleiotropic functions to mediate and regulate the immune response and are generally recognized as biomarkers of immunotoxicity. While the specificity and validity of certain cytokines as markers of adverse immune response has been established for chemicals, small and macromolecular drugs, research on their applicability for predicting and monitoring the immunotoxicity of engineered nanomaterials is still ongoing. The goal of this review is to provide guidelines as to important cytokines that can be utilized for evaluating the immunotoxicity of nanomaterials and to highlight the role of those cytokines in mediating adverse reactions, which is of particular importance for the clinical development of nanopharmaceuticals and other nanotechnology-based products. Importantly, the rational design of nanomaterials of low immunotoxicity will be discussed, focusing on synthetic nanodevices, with emphasis on both the nanoparticle-forming materials and the embedded cargoes.Keywords
This publication has 162 references indexed in Scilit:
- Delivery of siRNA into breast cancer cells via phage fusion protein-targeted liposomesNanomedicine: Nanotechnology, Biology and Medicine, 2011
- The Importance of Chemistry in Creating Well-Defined Nanoscopic Embedded Therapeutics: Devices Capable of the Dual Functions of Imaging and TherapyAccounts of Chemical Research, 2011
- Multifunctional Nanoemulsion Platform for Imaging Guided Therapy Evaluated in Experimental CancerACS Nano, 2011
- Structure-activity relationships of cationic shell-crosslinked knedel-like nanoparticles: Shell composition and transfection efficiency/cytotoxicityBiomaterials, 2010
- Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA deliveryJournal of Controlled Release, 2010
- Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacyAdvanced Drug Delivery Reviews, 2009
- In vitro assessments of nanomaterial toxicityAdvanced Drug Delivery Reviews, 2009
- An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumorJournal of Controlled Release, 2008
- Preclinical Studies To Understand Nanoparticle Interaction with the Immune System and Its Potential Effects on Nanoparticle BiodistributionMolecular Pharmaceutics, 2008
- Polymer-drug conjugates: Recent development in clinical oncologyAdvanced Drug Delivery Reviews, 2008